Chembio diagnostics reports first quarter 2021 financial results

Hauppauge, n.y., may 06, 2021 (globe newswire) -- chembio diagnostics, inc. (nasdaq: cemi), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the quarter ended march 31, 2021. chembio achieved first quarter 2021 total revenue of $8.7 million and product revenue of $4.0 million, representing growth of 27% and a decline of 30%, respectively, compared to the prior year period.
CEMI Ratings Summary
CEMI Quant Ranking